<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HEEA4E8C67D534AF388CE534D99E9600F" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 HR 6184 IH: Flu Vaccine Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2023-11-02</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">118th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 6184</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20231102">November 2, 2023</action-date><action-desc><sponsor name-id="D000216">Ms. DeLauro</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To conduct or support further comprehensive research for the creation of a universal influenza vaccine or preventative.</official-title></form><legis-body id="HEBFD9DBCFB0E4A38B40B8F255344C2B9" style="OLC"><section section-type="section-one" id="H282352784EE6426EACB24DCCAC199D5C"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Flu Vaccine Act</short-title></quote>.</text></section><section id="H3E69478585234BB280D55B23D731B9D6"><enum>2.</enum><header>Research for the creation of a universal influenza vaccine or preventative</header><subsection id="H5E45ED06FE79445C8DE78247DED6F44D"><enum>(a)</enum><header>In general</header><text>The Director of the National Institute of Allergy and Infectious Diseases shall conduct or support comprehensive research for the creation of a universal influenza vaccine or preventative.</text></subsection><subsection id="H19889D4BC3154BA5AEFF7F713F2962A6"><enum>(b)</enum><header>Authorization of appropriations</header><text>To carry out this section, there are authorized to be appropriated $200,000,000 for each of fiscal years 2024 through 2029.</text></subsection></section></legis-body></bill> 

